Table 1.
The Clinicopathologiccharacteristics of the Enrolled Urothelial Carcinoma Cases
| ClinicopathologicalCharacteristics | NO. (%) |
|---|---|
| Age category | |
| <60 years | 33 (53.2%) |
| ≥60 years | 29 (46.8%) |
| Sex | |
| Male | 56 (90.3%) |
| Female | 6 (9.7%) |
| Tumor location | |
| Bladder dome | 3 (7.9%) |
| Lateral wall | 16 (42.1%) |
| Anterior wall | 4 (10.5%) |
| Posterior wall | 5 (13.2%) |
| Bladder neck | 1 (2.6%) |
| Multifocal | 9 (23.7%) |
| Tumor size | |
| < 4.48 cm | 15 (57.7%) |
| ≥4.48 cm | 11 (42.3%) |
| Tumor grade | |
| High grade | 38 (61.3%) |
| Low grade | 24 (38.7%) |
| Tumor histological type | |
| Papillary | 34 (54.8%) |
| Non-papillary | 28 (45.2%) |
| Muscle invasion | |
| Muscle invasive | 26 (41.9%) |
| Non-muscle invasive | 36 (58.1%) |
| Schistosomal infestation | |
| Present | 12 (19.4%) |
| Absent | 50 (80.6%) |
| Lympho-vascular emboli | |
| Present | 19 (30.6%) |
| Absent | 43 (69.4%) |
| Perineural invasion | |
| Present | 7 (11.3%) |
| Absent | 55 (88.7%) |
| T-stage | |
| Ta | 15 (24.2%) |
| T1 | 21 (33.9%) |
| T2 | 4 (6.5%) |
| T3 | 19 (30.6%) |
| T4 | 3 (4.8%) |
| Lymph node stage | |
| N0 | 18 (69.2%) |
| N1 | 6 (23.1%) |
| N2 | 2 (7.7%) |